Americans are increasingly seeking innovative therapies for aging, chronic pain and longevityoften faster than science can provide definitive answers
For others, particularly those with a history of disordered eating, a GLP-1 appetite suppressant effect can complicate recovery by reinforcing restrictive patterns or making it harder to follow a meal plan
Also, should not be used in patients who are pregnant or breasfeeding or trying to get pregnant
In fact, recognizing them as overlapping rather than competing is the doorway to real relief
Kankaanranta H, Kauppi P, Tuomist LE, Ilmarinen P
By working collaboratively across the ecosystem, we help ensure that consumers have access to safe and effective solutions and medications. The End of the GLP-1 Shortage In October 2024, the FDA announced that the shortage of tirzepatide, the active ingredient in Mounjaro and Zepbound, was resolved, and shortages of other GLP-1s are also poised to be resolved in the near future